JH013 injection

BIOLOGICAL2 trials

Sponsors

Biotech Pharmaceutical Co., Ltd.

Conditions

Healthy Subjects (HS)Primary Sjögren's Syndrome (pSS)

Phase 1

A Phase I Clinical Trial of JH013 Injection

Not yet recruitingNCT06633055

Biotech Pharmaceutical Co., Ltd.Healthy Subjects (HS)

Start: 2024-10-31End: 2025-12-31Target: 32Updated: 2024-10-09

JH013 Injection in Patients With Primary Sjögren's Syndrome

Not yet recruitingNCT07818694

Biotech Pharmaceutical Co., Ltd.Primary Sjögren's Syndrome (pSS)

Start: 2026-09-30End: 2028-12-28Target: 54Updated: 2026-09-14